IL101925A - Catepsin G and elastase inhibitors to prevent connective tissue degeneration - Google Patents

Catepsin G and elastase inhibitors to prevent connective tissue degeneration

Info

Publication number
IL101925A
IL101925A IL10192592A IL10192592A IL101925A IL 101925 A IL101925 A IL 101925A IL 10192592 A IL10192592 A IL 10192592A IL 10192592 A IL10192592 A IL 10192592A IL 101925 A IL101925 A IL 101925A
Authority
IL
Israel
Prior art keywords
val
ala
pro
seq
group
Prior art date
Application number
IL10192592A
Other languages
English (en)
Hebrew (he)
Other versions
IL101925A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL101925A0 publication Critical patent/IL101925A0/xx
Publication of IL101925A publication Critical patent/IL101925A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymerisation Methods In General (AREA)
  • Vehicle Body Suspensions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Dental Preparations (AREA)
IL10192592A 1991-05-23 1992-05-19 Catepsin G and elastase inhibitors to prevent connective tissue degeneration IL101925A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70449991A 1991-05-23 1991-05-23

Publications (2)

Publication Number Publication Date
IL101925A0 IL101925A0 (en) 1992-12-30
IL101925A true IL101925A (en) 1996-03-31

Family

ID=24829789

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10192592A IL101925A (en) 1991-05-23 1992-05-19 Catepsin G and elastase inhibitors to prevent connective tissue degeneration

Country Status (17)

Country Link
US (1) US5510333A (hu)
EP (1) EP0587799B1 (hu)
JP (1) JP3442075B2 (hu)
AT (1) ATE181925T1 (hu)
AU (1) AU655301B2 (hu)
DE (1) DE69229552T2 (hu)
DK (1) DK0587799T3 (hu)
ES (1) ES2136091T3 (hu)
FI (1) FI935172A0 (hu)
GR (1) GR3031005T3 (hu)
HU (1) HU217612B (hu)
IL (1) IL101925A (hu)
NO (1) NO934218D0 (hu)
NZ (1) NZ242807A (hu)
PT (1) PT100517B (hu)
WO (1) WO1992020357A1 (hu)
ZA (1) ZA923602B (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
EP0635028B1 (en) * 1992-04-10 2003-01-22 Abbott Laboratories Pulmonary surfactant protein fragments
CA2137832C (en) * 1992-06-12 2000-09-26 Dennis J. Hoover Inhibitors of angiotensin i chymase(s) including human heart chymase
US6008196A (en) * 1994-06-02 1999-12-28 Hoechst Marion Roussel, Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
JP4221059B2 (ja) * 1994-06-02 2009-02-12 アベンティス・インコーポレイテッド エラスターゼインヒビターのプロドラッグとしてのアシル化エノール誘導体
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US5693515A (en) * 1995-04-28 1997-12-02 Arris Pharmaceutical Corporation Metal complexed serine protease inhibitors
DE19543750C2 (de) * 1995-11-24 1997-10-23 Crinos Industria Farmaco Cathepsin G inhibierende Aptamere
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
CA2251714A1 (en) * 1996-04-22 1997-10-30 Massachusetts Institute Of Technology Suppression of immune response via inhibition of cathepsin s
JP2002047256A (ja) * 2000-07-26 2002-02-12 Kanegafuchi Chem Ind Co Ltd α−アミノ−α´,α´,α´−トリハロケトン誘導体、α−アミノ−α´,α´,α´−トリハロアルコ−ル誘導体、及び、α−ヒドロキシ−β−アミノカルボン酸誘導体の製造法
WO2008054144A1 (en) * 2006-11-03 2008-05-08 Amorepacific Corporation Skin external composition containing cathepsin g inhibitors for preventing skin aging and the screening method for development of antiaging materials
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
JP2023500182A (ja) 2019-09-17 2023-01-05 メレオ バイオファーマ 4 リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
EP4106757B1 (en) 2020-04-16 2023-08-23 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
KR20230038457A (ko) 2020-06-10 2023-03-20 알리고스 테라퓨틱스 인코포레이티드 코로나바이러스, 피코르나바이러스 및 노로바이러스 감염을 치료하기 위한 항바이러스 화합물
AU2022306289A1 (en) 2021-07-09 2024-01-18 Aligos Therapeutics, Inc. Anti-viral compounds
US12065428B2 (en) 2021-09-17 2024-08-20 Aligos Therapeutics, Inc. Anti-viral compounds
TW202325294A (zh) 2021-10-20 2023-07-01 英商梅瑞奧生物製藥4有限公司 用於治療纖維化之嗜中性球彈性蛋白酶抑制劑

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230275A1 (de) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen Elastaseinhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
US4629724A (en) * 1984-12-03 1986-12-16 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitors
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
DE3683541D1 (de) * 1985-06-07 1992-03-05 Ici America Inc Selektionierte difluorverbindungen.
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity
EP0307662A3 (en) * 1987-08-24 1990-07-25 Kabushiki Kaisha Vitamin Kenkyusyo Enkephalin analogs
EP0356595A1 (en) * 1988-09-01 1990-03-07 Merrell Dow Pharmaceuticals Inc. Novel peptidase inhibitors
ZA897515B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
CA2021660A1 (en) * 1989-07-26 1991-01-27 Philippe Bey Peptidase inhibitors
DE3938971A1 (de) * 1989-11-24 1991-05-29 Biotechnolog Forschung Gmbh Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat

Also Published As

Publication number Publication date
ZA923602B (en) 1993-02-24
NO934218L (no) 1993-11-22
FI935172A (fi) 1993-11-22
JP3442075B2 (ja) 2003-09-02
NZ242807A (en) 1994-07-26
DK0587799T3 (da) 1999-11-22
AU655301B2 (en) 1994-12-15
HU9303314D0 (en) 1994-03-28
IL101925A0 (en) 1992-12-30
GR3031005T3 (en) 1999-12-31
ATE181925T1 (de) 1999-07-15
DE69229552D1 (de) 1999-08-12
US5510333A (en) 1996-04-23
JPH06508355A (ja) 1994-09-22
WO1992020357A1 (en) 1992-11-26
EP0587799B1 (en) 1999-07-07
AU2184192A (en) 1992-12-30
PT100517A (pt) 1993-09-30
FI935172A0 (fi) 1993-11-22
HU217612B (hu) 2000-03-28
NO934218D0 (no) 1993-11-22
EP0587799A1 (en) 1994-03-23
ES2136091T3 (es) 1999-11-16
HUT65140A (en) 1994-04-28
PT100517B (pt) 1999-06-30
EP0587799A4 (en) 1995-06-14
DE69229552T2 (de) 1999-12-23

Similar Documents

Publication Publication Date Title
EP0587799B1 (en) Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
JP2700511B2 (ja) Hivプロテアーゼ阻害剤
JP3203579B2 (ja) 新規なペプチダーゼ阻害剤類
JP3721538B2 (ja) エラスターゼのパーフルオロアルキルケトン阻害剤およびそれらを製造する方法
US5736520A (en) Peptidase inhibitors
EP0410411A2 (en) Novel peptidase inhibitors
AU2499092A (en) New isosteric peptides
EP0195212A2 (en) Novel peptidase inhibitors
CA2024661A1 (en) Peptidase and isomerase inhibitors
WO1989005819A1 (en) Novel hydroxamic acid derivative
CH635571A5 (fr) Tetrapeptides et composition therapeutique les contenant.
JPH10500992A (ja) 新しいエラスターゼ阻害剤
JPH02172961A (ja) 新規なペプチダーゼ基質類似体
FR2471971A1 (fr) Tetrapeptides homologues des enkephalines, leur preparation et leur utilisation therapeutique
JPH0356496A (ja) フルオロアミド誘導体
JPH02117649A (ja) 新規なペプチダーゼ阻害剤
KR100230541B1 (ko) 결합 조직 퇴화 방지용 카뎁신 g 및 엘라스타제의 억제제
HU208838B (en) Method for producing peptones containing aza aminoacides by means of solid-phase synthesis
EP0948524A1 (fr) Peptides agonistes du recepteur b 2? de la bradykinine
CA2191844C (en) Acylated enol derivatives as prodrugs of elastase inhibitors
JPH0548237B2 (hu)
JPH09227591A (ja) オリゴペプチドアルデヒドの製造方法
JPS61122298A (ja) アミノチオールペプチド類
JPH0229670B2 (hu)
ATSUUMI et al. Renin inhibitors. II. Synthesis and structure-activity relationships of N-terminus modified inhibitors containing a homostatine analogue

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees